SV Analysis
Overview
SV (Structural Variant) Analysis Service is a cutting-edge genomic research solution dedicated to the comprehensive detection, characterization, and interpretation of structural variants within DNA sequences. Structural variants, encompassing a broad range of genomic alterations such as insertions, deletions, inversions, translocations, and duplications, are key drivers of genetic diversity, disease pathogenesis, evolutionary processes, and phenotypic variation. These variants can span from a few base pairs to several megabases, significantly impacting gene function, regulatory networks, and chromosomal architecture. By systematically mapping and analyzing SVs across genomes, our service provides profound insights into genomic plasticity, disease mechanisms, and population genetics dynamics. It synergizes advanced molecular techniques, high-performance computing, and bioinformatics tools to accurately quantify SVs, evaluate their functional consequences, and explore their biological and biomedical significance.
Our SV Analysis Service Enhances Your Research with:
- High-Resolution SV Detection: Utilize state-of-the-art next-generation sequencing (NGS) and long-read sequencing platforms (e.g., PacBio SMRT, Oxford Nanopore Technologies) to achieve unparalleled accuracy in SV identification, even in challenging genomic regions characterized by repeats or complex rearrangements.
- Comprehensive SV Characterization: Employ a suite of algorithms and software tools (e.g., Manta, Delly, Sniffles) to classify SVs into distinct categories, determine their exact breakpoints, and estimate their sizes, providing a detailed portrait of genomic structural heterogeneity.
- Functional Impact Assessment: Predict the biological effects of SVs on gene expression, splicing patterns, protein function, and non-coding regulatory elements using in silico prediction tools (e.g., Ensembl Variant Effect Predictor, REMM) and integrate these findings with functional genomics data sets for a holistic understanding.
- Pathway and Network Analysis: Link detected SVs to biological pathways and interaction networks using databases like KEGG, Reactome, and STRING, revealing potential roles in disease pathways, cellular processes, or developmental programs.
- Population Genetics and Evolutionary Studies: Analyze SV frequencies and distributions across diverse populations or species to uncover patterns of genetic variation, signatures of natural selection, demographic history, or adaptive evolution, employing statistical methods such as PCA, admixture analysis, and selection scans.
- Disease-Associated SV Discovery: Conduct targeted or genome-wide association studies (GWAS) to identify SVs linked to complex traits or genetic disorders, leveraging case-control designs, burden tests, or meta-analyses to enhance statistical power and discover novel disease loci.
- Cancer Genomics Applications: Specialized pipelines for cancer SV analysis, including the detection of fusion genes, chromothripsis events, and kataegis patterns, facilitating the discovery of driver mutations and the understanding of tumor heterogeneity and evolution.
- Customized Reporting and Visualization: Generate detailed, user-friendly reports summarizing SV findings, along with interactive visualizations (e.g., Circos plots, IGV tracks) to facilitate data interpretation, hypothesis generation, and presentation of results.
What Is InDel Analysis
SV Analysis integrates multi-omics datasets, such as transcriptomics, epigenomics, and proteomics, to gain a holistic understanding of how structural variants affect gene expression, regulatory networks, and protein function. This integrative approach enables researchers to uncover the molecular pathways and biological processes disrupted by SVs, providing insights into their contributions to phenotypic diversity and disease pathogenesis. By mapping the distribution and frequency of structural variants across different genomes, SV Analysis Service reveals how these genomic alterations contribute to genetic variation within and between populations, shaping the genetic landscape of species over time. It explores the role of SVs in driving speciation events, promoting adaptive evolution in response to environmental pressures, and influencing the susceptibility to complex diseases, including cancer, neurological disorders, and congenital abnormalities.
How to Measure
1. Sample Collection and Study Design
Target Populations/Groups
- Define Biological Questions:
- Human disease genetics: Case-control cohorts for rare disease-associated SV discovery.
- Evolutionary Biology: Geographically isolated populations or hybrid zones to study adaptive SVs.
- Agriculture: Crop varieties or livestock breeds for trait-associated SV screening.
- Sample Types:
- Humans: Blood, saliva, or buccal swabs (for population studies).
- Animals/Plants: Tissue biopsies (e.g., fin clips, leaves), non-invasive samples (e.g., feces, hair), or environmental DNA (eDNA).
- Microorganisms: Metagenomic samples (soil, water) or cultured isolates (for horizontal gene transfer analysis).
Sampling Strategy
- Spatial Replication: Include multiple sampling sites to capture population structure.
- Temporal Replication: Resample populations over time to track SV frequency changes (e.g., post-environmental stress).
- Replication Depth: Aim for ≥10 samples per group to ensure statistical power.
Genomic Data Generation
Table 1: SV-Oriented Sequencing Approaches
| Technology |
Application Scenario |
Key Advantages |
| Whole-Genome Sequencing (WGS) |
Deep ancestry inference, rare SV detection |
Full genomic coverage; no ascertainment bias. |
| Targeted Panel Sequencing |
Disease-focused gene panels (e.g., cancer genes) |
Cost-effective for high-depth sequencing of known genes. |
| Long-Read Sequencing (PacBio/Nanopore) |
Complex SVs in repetitive regions |
Resolves structural variants missed by short reads. |
| ddRAD-seq/GBS |
Non-model organisms, low-budget studies |
Reduced genome complexity; unbiased locus sampling. |
Sample-Level QC
- Remove low-quality samples:
- Coverage threshold: <10x for WGS; <30x for targeted panels.
- Missing data: Exclude samples with >20% missing genotypes.
- Relatedness: Filter closely related individuals (e.g., PI_HAT > 0.125 in PLINK).
- Variant-Level QC
- Filter SVs by:
- Allele Frequency: Exclude singletons/doubletons (MAF < 1% for small cohorts).
- Genotype Quality: Remove calls with Phred score <30.
- Functional Impact: Prioritize SVs in coding regions or splice sites.
2. SV Detection and Genotyping
Variant Calling Pipelines
- Short Reads (Illumina):
- Tools: GATK HaplotypeCaller, FreeBayes, DeepVariant.
- Output: VCF files with SV calls, genotypes, and quality metrics.
- Long Reads (PacBio/Nanopore):
- Tools: Sniffles, CuteSV, NGMLR.
- Advantage: Detect large SVs (>50 bp) and complex rearrangements.
- Multi-Sample Genotyping
- Use GATK GenotypeGVCFs or GLnexus to jointly call SVs across cohorts, improving accuracy for low-frequency variants.
3. Functional Annotation and Impact Prediction
Annotation Tools
- Coding Regions:
- SnpEff/VEP: Predict frameshifts, in-frame insertions/deletions.
- PolyPhen-2/SIFT: Assess protein damage likelihood.
- Non-Coding Regions:
- RegulomeDB: Link SVs to transcription factor binding sites.
- CADD: Score deleteriousness for regulatory variants.
Pathway Enrichment Analysis
- Tools: DAVID, g:Profiler, or clusterProfiler (R).
- Objective: Identify overrepresented pathways (e.g., DNA repair, immune signaling) disrupted by SVs.
4. Population Genetics and Evolutionary Analysis
Genetic Diversity Metrics
- Calculate π (nucleotide diversity), θw (Watterson's theta), and Tajima's D to assess selection pressures.
Population Structure Analysis
- Tools: PCA (PLINK/EIGENSOFT), ADMIXTURE, STRUCTURE.
- Output: Visualize clusters and admixture events (e.g., bar plots, PCA scatterplots).
Selection Scans
- FST Outliers: Identify SVs with extreme differentiation between populations (e.g., using VCFtools or scikit-allel).
- iHS/XP-EHH: Detect ongoing positive selection in sliding windows.
5. Biomedical and Agricultural Research Interpretation
Disease Association Studies
- Case-control analysis: Test for SV enrichment in affected individuals (e.g., Fisher's exact test).
- Pharmacogenomics: Correlate SVs in drug-metabolizing genes (e.g., CYP2C19) with drug-response phenotypes.
Crop/Livestock Breeding
- GWAS: Link SVs to agronomic traits (e.g., yield, drought tolerance).
- Haplotype Analysis: Track favorable SV-linked haplotypes across breeding generations.
6. Visualization and Reporting
Key Visualizations
- Circos Plots: Display SV distribution across chromosomes.
- Manhattan Plots: Highlight loci under selection (e.g., FST outliers).
- Lollipop Plots: Show SV positions in protein domains (e.g., using MutationMapper).
Interactive Reports
- Deliverables:
- Annotated VCF files with functional predictions.
- Custom R/Shiny dashboards for exploratory analysis.
- Publication-ready figures (e.g., PCA, admixture, selection scans).
Figure 1: SV Analysis
What Can We do
Comprehensive Genomic Coverage: We combine whole-genome sequencing (WGS) data with exome sequencing or reduced-representation libraries (e.g., RAD-seq, GBS) to capture a wide spectrum of structural variants across the genome. This multi-layered approach ensures that no variant goes undetected, from large insertions and deletions to complex rearrangements.

Contextualizing SVs: By integrating genomic data with ecological, phenotypic, and geographic datasets, we provide a holistic view of SV distributions across species, populations, or environmental gradients. This contextualization helps in understanding how structural variants respond to and shape the biological and ecological niches they inhabit.

Contemporary Migration Patterns: Using Bayesian approaches like Migrate-n, BayesAss, or LEA, we quantify contemporary migration rates (M = migrants per generation) and directionality between populations. This information is crucial for understanding gene flow dynamics, population connectivity, and the spread of genetic variants across landscapes.

Conservation Genetics: Bayesian gene flow estimation aids in conservation efforts by identifying genetically distinct populations, assessing the impact of habitat fragmentation on gene flow, and informing management strategies aimed at preserving genetic diversity and preventing inbreeding.

Speciation and Hybridization: Coalescent-based methods also help us understand the role of structural variants in speciation processes and hybridization events, shedding light on the genomic mechanisms underlying the origin and maintenance of biodiversity.
Our Advantages
- RegulomeDB & Epigenomic Data Integration
For SVs located in non-coding regions, we utilize databases like RegulomeDB to assess their potential impact on regulatory elements such as enhancers, promoters, and insulators. By integrating epigenomic data, we can determine whether an SV might disrupt or create regulatory interactions, thereby influencing gene expression patterns.
- Selective Sweep Detection
Using statistical methods and population genetic models, we scan genomes for signatures of selective sweeps—regions where a beneficial SV has rapidly increased in frequency, leaving a characteristic pattern of reduced genetic diversity. Identifying such sweeps provides evidence for the adaptive significance of specific SVs.
- Haplotype Network & Phylogenetic Analysis
By constructing haplotype networks and phylogenetic trees, we can trace the evolutionary relationships between different alleles or SV-containing genomic regions. This allows us to infer the timing and geographic spread of SVs, as well as their role in speciation events or population divergence.
- Functional & Evolutionary Interpretation
At the heart of our SV Analysis service lies a profound commitment to not just identifying structural variants (SVs) but also to unraveling their biological significance and evolutionary implications. We recognize that SVs are not merely genomic curiosities; they are dynamic elements that can profoundly influence gene expression, protein function, and the overall architecture of the genome.
Applications
1. Conservation of Endangered Species
SV analysis, much like InDel analysis, is instrumental in safeguarding the genetic diversity of endangered species and mitigating the risks of inbreeding in fragmented populations. By identifying unique SV markers, researchers can gain a deeper understanding of the genetic distinctiveness and connectivity between isolated groups. For instance, in the case of the critically endangered Javan rhinoceros, SV profiling uncovered specific genomic rearrangements that may contribute to its limited adaptability and vulnerability to environmental changes. This knowledge prompted the establishment of genetic corridors to facilitate gene flow between subpopulations. These insights are crucial for guiding habitat conservation efforts and implementing genetic rescue strategies to maintain the evolutionary resilience of endangered species.
2. Invasive Species Management
SVs play a significant role in the adaptive potential of invasive species, driving their ability to thrive in new environments. By comparing the SV landscapes of invasive and native taxa, scientists can pinpoint genomic regions that underlie traits such as pesticide resistance, drought tolerance, or competitive advantage. For example, in the case of the European green crab, an invasive species wreaking havoc on coastal ecosystems, SV analysis revealed genetic variants associated with rapid shell hardening, enabling it to evade predators more effectively. Targeting these SVs through gene editing or biocontrol strategies offers a promising avenue for curbing invasions while preserving native biodiversity and agricultural productivity.
3. Human Migration and Health Disparities
SVs serve as molecular signatures that trace the ancient migrations of human populations and their associated health impacts. For instance, SV variants in genes related to immune function reflect population-specific selective pressures during migration, influencing susceptibility to infectious diseases. In Indigenous populations of the Amazon rainforest, SVs in genes involved in detoxification pathways reveal adaptations to a diet rich in plant toxins, offering insights into the etiology of certain metabolic disorders in modernized communities. Furthermore, SV-informed ancestry analyses in admixed populations, such as Latino communities, highlights genetic variants associated with differential risk of complex diseases such as diabetes and cardiovascular conditions.
Demo
Figure 2: Overall structures of the Omicron S-trimer. (Zhen, 2022)
Assessing the clinical utility of protein structural analysis in genomic variant classification: experiences from a diagnostic laboratory
Journal: Genome Med
Published: 2022
The widespread application of genome-wide sequencing has resulted in many new findings in rare genetic conditions, but testing regularly identifies variants of uncertain significance (VUS). The remarkable rise in the amount of genomic data has been paralleled by a rise in the number of protein structures that are now publicly available, which may have utility for the interpretation of missense and in-frame insertions or deletions.
Within a UK National Health Service genomic medicine diagnostic laboratory, the study investigated the number of VUS over a 5-year period that were evaluated using protein structural analysis and how often this analysis aided variant classification.
The study found 99 novel missense and in-frame variants across 67 genes that were initially classified as VUS by our genomic medicine laboratory using standard variant classification guidelines and for which further analysis of protein structure was requested. Evidence from protein structural analysis was used in the re-assessment of 64 variants, of which 47 were subsequently reclassified to higher-confidence categories and 17 remained as VUS. We identified several case studies where protein structural analysis aided variant interpretation by predicting disease mechanisms that were consistent with the observed phenotypes, including loss-of-function through thermodynamic destabilisation or disruption of ligand binding, and gain-of-function through de-repression or escape from proteasomal degradation.
Figure 3: CASR NM_000388.3:c.488C > G, p.(Pro163Arg).
FAQs
How is SV Analysis different from traditional genetic variant analysis?
Traditional genetic variant analysis primarily focuses on single nucleotide polymorphisms (SNPs) and small insertions/deletions (InDels). While these variants are important, they often have subtle effects on gene function. SV Analysis, on the other hand, examines larger genomic rearrangements that can disrupt genes, alter gene dosage, or create novel fusion genes. These structural changes can have profound biological consequences, making SV Analysis essential for a comprehensive understanding of genomic variation and its implications.
Is SV Analysis expensive and time-consuming?
The cost and time required for SV Analysis depend on several factors, including the sequencing technology used, the size and complexity of the genome, and the computational resources available. While WGS and long-read sequencing can be more expensive and time-consuming than traditional methods, they offer higher resolution and accuracy in SV detection. Advances in sequencing technologies and bioinformatics tools are continuously reducing costs and improving efficiency, making SV Analysis more accessible to researchers across various fields.
References
- Cui Z, Liu P, Wang N, Wang L, Fan K, Zhu Q, Wang K, Chen R, Feng R, Jia Z, Yang M, Xu G, Zhu B, Fu W, Chu T, Feng L, Wang Y, Pei X, Yang P, Xie XS, Cao L, Cao Y, Wang X. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell. 2022 Mar 3;185(5):860-871.e13. https://doi.org/10.1016/j.cell.
- Caswell RC, Gunning AC, Owens MM, Ellard S, Wright CF. Assessing the clinical utility of protein structural analysis in genomic variant classification: experiences from a diagnostic laboratory. Genome Med. 2022 Jul 22;14(1):77. https://doi.org/10.1186/s13073-022-01082-2
* Designed for biological research and industrial applications, not intended
for individual clinical or medical purposes.